| Mean age (range) [years] |
58.1 ± 13.8 (19–81) |
| Females |
15 (79%) |
| Time between iniciating event and complex regional pain syndrome |
|
| < 1 week |
10 (52.6%) |
| < 1 month |
1 (5.3%) |
| < 2 months |
6 (31.6%) |
| > 2 months |
2 (10.5%) |
| Iniciating event |
|
| with surgery
|
13 (68.4%) |
| Fracture |
8 (42.1%) |
| Soft tissue injury |
3 (15.8%) |
| Joint injury |
2 (10.5%) |
| without surgery
|
6 (31.6%) |
| Fracture |
3 (15.8%) |
| Soft tissue injury |
3 (15.8%) |
| Joint injury |
0 |
| Time between onset of CRPS and examination at visit 1 (range) [months] |
5.7 ± 8.3 (1–33) |
| Acute CRPS (< 6 months) |
17 |
| Chronic CRPS (≥ 2 years) |
2 |
| Time between visit 1 and follow-up (range) [months] |
36 ± 10.6 (16–53) |
| Ongoing pain medication at follow-up |
4 (21.1%) |
| Non-steroidal anti-inflammatory drugs |
2 (10.5%) |
| Antidepressants |
1 (5.3%) |
| Anticonvulsants |
1 (5.3%) |
| Low potent opioids |
2 (10.5%) |
| High potent opioids |
1 (5.3%) |
| Concomitant treatment at follow-up |
2 (10.5%) |
| Physiotherapy |
2 (10.5%) |
| Occupational therapy |
0 |
| Psychotherapy |
0 |
| Transcutaneous electrical nerve stimulation |
0 |
| Interventional treatment (sympathetic blocks, ganglionic local opioid analgesia) |
0 |
| Invasive treatment (spinal cord stimulation, deep brain stimulation, neurodestructive procedures) |
0 |
